Human Vaccines

670 papers and 16.1k indexed citations i.

About

The 670 papers published in Human Vaccines in the last decades have received a total of 16.1k indexed citations. Papers published in Human Vaccines usually cover Epidemiology (345 papers), Infectious Diseases (191 papers) and Immunology (137 papers) specifically the topics of Influenza Virus Research Studies (126 papers), Vaccine Coverage and Hesitancy (119 papers) and Bacterial Infections and Vaccines (102 papers). The most active scholars publishing in Human Vaccines are Ian F. Cook, Barbara Romanowski, Vidadi Yusibov, Luis G. Bermúdez‐Humarán, Polly Roy, Rob Noad, Natasha Kushnir, Christelle Liard, Béhazine Combadière and Stephen J. Streatfield.

In The Last Decade

Fields of papers published in Human Vaccines

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Human Vaccines. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Human Vaccines

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Human Vaccines. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Human Vaccines with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025